News

Pharmaceutical Technology22h
NICE endorses CSL Vifor’s sparsentan for IgA nephropathy in adults
The NICE has issued final draft guidance endorsing the use of CSL Vifor's Filspari (sparsentan) for primary IgA nephropathy.
Pharmaceutical Technology21h
ASCO25: Roche’s Itovebi combo reduces risk of death in breast cancer by 33%
In combination with Pfizer’s CDK4/6 inhibitor Ibrance (palbociclib) and anti-oestrogen drug Faslodex (fulvestrant), Itovebi ...
Pharmaceutical Technology20h
Genentech to onshore US manufacturing amid rising drug pricing tensions
Genentech has announced an investment exceeding $700m to establish its first East Coast manufacturing facility in North ...